A review of telavancin activity in in vitro biofilms and animal models of biofilm-associated infections

Update of the telavancin activity in vitro tested against a worldwide collection of Gram-positive clinical isolates (2013), when applying the revised susceptibility testing method

(2015) Rodrigo E. Mendes et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Revised Reference Broth Microdilution Method for Testing Telavancin: Effect on MIC Results and Correlation with Other Testing Methodologies

(2014) David J. Farrell et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Telavancin shows superior activity to vancomycin with multidrug-resistant Staphylococcus aureus in a range of in vitro biofilm models

(2013) K. Smith et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Role of efflux pumps in the antibiotic resistance of bacteria embedded in a biofilm

(2013) Sara M. Soto   Virulence

Telavancin in Therapy of Experimental Aortic Valve Endocarditis in Rabbits Due to Daptomycin-Nonsusceptible Methicillin-Resistant Staphylococcus aureus

(2012) Yan Q. Xiong et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Worldwide Appraisal and Update (2010) of Telavancin Activity Tested against a Collection of Gram-Positive Clinical Pathogens from Five Continents

(2012) Rodrigo E. Mendes et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Evaluation of Telavancin Activity versus Daptomycin and Vancomycin against Daptomycin-Nonsusceptible Staphylococcus aureus in anIn VitroPharmacokinetic/Pharmacodynamic Model

(2011) Molly E. Steed et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In vitro activity of telavancin and comparator antimicrobial agents against a panel of genetically defined staphylococci

(2011) David J. Farrell et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Antibiotic resistance of bacterial biofilms

(2010) Niels Høiby et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Activity of telavancin against heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) in vitro and in an in vivo mouse model of bacteraemia

(2010) S. S. Hegde et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

In Vitro Activities of Telavancin and Vancomycin against Biofilm-Producing Staphylococcus aureus, S. epidermidis, and Enterococcus faecalis Strains

(2009) K. L. LaPlante et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Comparative Efficacies of Telavancin and Vancomycin in Preventing Device-Associated Colonization and Infection by Staphylococcus aureus in Rabbits

(2009) R. O. Darouiche et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Activity of Telavancin against Staphylococcus aureus Strains with Various Vancomycin Susceptibilities in an In Vitro Pharmacokinetic/Pharmacodynamic Model with Simulated Endocardial Vegetations

(2009) S. N. Leonard et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Osteomyelitis and the role of biofilms in chronic infection

(2009) Rebecca A. Brady et al.   FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY

Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections: Annual Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007

(2008) Alicia I. Hidron et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Efficacy of telavancin in the treatment of methicillin-resistant Staphylococcus aureus osteomyelitis: studies with a rabbit model

(2008) L.-Y. Yin et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY